国产999免费视频|亚洲欧美激情综合首页|动漫人妻h无码中文字幕|国产精品欧美日韩视频一区|美女精品人妻视频一区二区|中文亲近交尾bd在线播放|色五月丁香亚洲高清无码国产|久久一区国产男人操女人的视频

position: EnglishChannel  > Policy> Innovation Credit System to Motivate High-tech SMEs

Innovation Credit System to Motivate High-tech SMEs

Source: Science and Technology Daily | 2024-08-28 10:46:29 | Author: LIU Yin & CHEN Chunyou

The Innovation Credit System (ICS), piloted in 2020, is set for an upgrade and expansion. Originally implemented in national high-tech zones, it will now be put on trial nationwide targeting technology-oriented small and medium-sized enterprises (SMEs) to help them grow and stand out.

This was stated by an ICS guideline (national trial version) released by the general office of the Ministry of Science and Technology (MOST) on August 13.

The ICS quantifies the innovation capabilities of enterprises through a set of innovation credit indicators, converting their innovation capacity into "financial data" that investment institutions can easily understand. This approach will help SMEs secure financial backing.

The ICS has three main indicators. The first is technological innovation, including seven metrics such as R&D expenditure amount, R&D expenditure growth rate, and the turnover of enterprise technology contracts. The second is growth and operation indicators, including six metrics such as high-tech product revenue and net asset profitability. The third includes auxiliary indicators, with five metrics such as the number of fresh graduates hired and the amount of obtained venture capital.

Innovation credit evaluations will be used in areas such as re-lending for technological innovation and special plans for science and technology innovation guarantees. Enterprises with high credits will be highly recommended.

The guideline also provides specific implementation recommendations. For instance, banks and other financial institutions can use innovation credit as a reference for risk assessment and credit enhancement to give technology-oriented SMEs more targeted financial services. Venture capital institutions and capital markets can use enterprise innovation credits as a reference to increase equity investments and listing support for outstanding enterprises.

Management departments are encouraged to support outstanding credit enterprises in applying for national science and technology projects and talent projects, ensuring that high-quality resources are precisely directed towards highly innovative enterprises.

By late 2023, the ICS had been piloted in 133 high-tech zones, covering 25 provincial-level regions. It has played a positive role in guiding fiscal and tax policies, sci-tech resources, talent teams, and financial investment.

ICS participants include the Industrial and Commercial Bank of China, the Agricultural Bank of China, and the Bank of China. They launched special financial products for SMEs, some of which can directly issue unsecured credit loans to technology-oriented SMEs.

This year, the People's Bank of China, together with MOST and other related departments, set up a science and technology innovation re-loan worth 100 billion RMB. On the basis of innovation credit evaluation, about 3,000 enterprises will be selected in two batches and recommended to 21 banks for sci-tech innovation re-loans.

Editor:CHEN Chunyou

Top News

Jointly Protecting People's Rights in Digital Era

?Emerging technologies like AI, big data and the Internet of Things are rapidly reshaping the world in this era of digital intelligence. However, they are also bringing challenges to human rights, which makes joint efforts essential. Science and Technology Daily spoke with international experts on these issues against the backdrop of the 2025 China-Europe Seminar on Human Rights hosted by the China Society for Human Rights Studies and Cátedra China Foundation in Madrid, Spain, on June 25 on the theme "Human Rights in the Era of Digital Intelligence."

First Human Clinical Trial of Invasive BCI in China

A major breakthrough in neurotechnology has been achieved with the successful completion of China's first-in-human clinical trial of an invasive brain-computer interface (BCI) system. With that China becomes the second country in the world to reach the clinical stage in this field.

抱歉,您使用的瀏覽器版本過低或開啟了瀏覽器兼容模式,這會影響您正常瀏覽本網(wǎng)頁

您可以進行以下操作:

1.將瀏覽器切換回極速模式

2.點擊下面圖標升級或更換您的瀏覽器

3.暫不升級,繼續(xù)瀏覽

繼續(xù)瀏覽
东宁县| 贡嘎县| 商南县| 井研县| 长乐市| 安阳市| 桐梓县| 长春市| 麟游县| 葫芦岛市| 襄汾县| 顺义区| 桃园县| 明星| 渝北区| 永善县| 剑阁县| 彰化县| 崇阳县| 化隆| 富宁县| 广平县| 伊川县| 喜德县| 镇巴县| 和田市| 陇西县| 沈阳市| 科技| 巴林左旗| 洮南市| 长春市| 泰宁县| 迭部县| 同心县| 腾冲县| 抚顺市| 湖州市| 商南县| 泾源县| 临夏市|